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Abstract 
Recent research on treatment preference for individuals with major depressive disorder indicates 
a three to one ratio of preference for cognitive behavioral therapy over medication. There has 
been little to no research on treatment preference for exercise. Exercise has the properties of 
being easily accessible and cost efficient, where other treatments may be costly. The present 
study investigates treatment preference for major depressive disorder with the inclusion of 
exercise as one of the treatment options. There was a total of 389 participants who completed a 
questionnaire that included a scenario of someone who was diagnosed with major depressive 
disorder, followed by questions with regards to how likely each participant would choose 
Sertraline, cognitive behavioral therapy, or exercise, and if the participants could only choose 
one treatment option, which one would they prefer. Results were consistent with previous 
research where cognitive behavioral therapy was significantly preferred over Sertraline. When 
exercise was compared to Sertraline, participants significantly preferred exercise over Sertraline. 
There are implications for future research in relation to treatment preference of exercise for 
major depressive disorder.   
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Introduction 
The psychological disorder of depression, also known as the common cold of outpatients, 
is a significant problem in the United States with about 25 million people meeting the criteria for 
some type of depressive disorder (Keller, 1994). Major depressive disorder alone affects about 
15 million people, which is about 6.7 percent of Americans (Facts & statistics, 2016). According 
to the Facts & statistics (2016), major depressive disorder is the leading cause of disability 
among people between the ages of 15 and 44, and can interfere with daily life goals or activities 
such as education and stability in marriages (Kessler, 2012). For example, previous research has 
shown that major depressive disorder is associated with 60% increased risk of failure to complete 
intermediate school, and depressed individuals are much more likely to  experience marital 
divorce (Breslau et al., 2011). In addition, major depressive disorder is also associated with 
increased attention, memory, executive function, and psychomotor speed dysfunction (Gonda et 
al., 2015). The annual health care costs associated with major depressive disorder are also nearly 
double the annual health care cost for people who do not meet the criteria for the disorder 
(Simon, VonKorff, & Barlow, 1995). 
Given the societal and personal costs associated with depression, there has been a strong 
emphasis on identifying and developing effective treatments (Holtzheimer & Mayberg, 2011). 
To date, several treatments have been shown to be effective in reducing symptoms of depression 
and improving quality of life. Of the effective treatments, one that is generally administered to 
people with depression is cognitive behavioral therapy (CBT). In a meta-analysis that analyzed 
the effectiveness of CBT across 26 studies, researchers found a within-study comparison mean 
effect size of 1.73 when CBT was compared with the control group (Gaffan, Tsaousis, & Kemp-
Wheeler, 1996). In relation to other forms of psychotherapy, the mean effect size of CBT was 
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0.24. The overall mean effect size for other psychotherapy was 1.28, which was much higher 
than the waiting-list control mean of 0.13 (Gaffan, Tsaousis, & Kemp-Wheeler, 1996). For the 
between-studies comparison, researchers found that the mean effect size of CBT, when 
compared to the control group, was 0.93. When comparing CBT to other psychotherapy, the 
mean effect size was 0.32 (Gaffan, Tsaousis, & Kemp-Wheeler, 1996). These findings suggest 
that CBT is significantly more effective than the control group for treating depression.   
 Antidepressant medication is another form of treatment for treating depression (Pubmed 
Health, 2017). Previous research on antidepressant medications indicates that the effectiveness of 
a drug is unpredictable (PubMed Health, 2017). Doctors generally prescribe patients with the 
most effective medication they know of and if that medication does not work, they switch the 
patient to a different medication (Smith, 2012). Figuring out the exact medication that works for 
each patient specifically can be challenging. The effectiveness of antidepressant medication 
depends primarily on how severe the depression is (Smith, 2012). The more severe the 
depression is the more effective antidepressant medication is. For instance, Fournier and 
colleagues (2010) conducted a study that analyzed the effectiveness of antidepressant medication 
for different severities of depressive symptoms (mild, moderate, severe, or very-severe), and how 
the effects compared to the placebo. The researchers concluded that for mild to severe depressive 
symptoms, effectiveness of antidepressant medications did not differ from placebo, whereas 
effectiveness did differ for very-severe depression (Fournier et al., 2010). Therefore, 
antidepressant medication best works for patients diagnosed with severe depression.  
 Alternative interventions are now starting to emerge for treating depression relative to 
CBT and antidepressant medication. Alternative interventions to the commonly used treatments 
include exercise, yoga, and meditation (Saeed, Antonacci, & Bloch, 2010). These interventions 
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have demonstrated effectiveness in previous studies when compared to no-activity controls, and 
are essentially ideal for easy accessibility (Nahas & Sheikh, 2011). When looking specifically at 
exercise, in a previous meta-regression that compared exercise with placebo interventions for 
treating depression, the standardized mean differences in effect size was -1.1 (Lawlor, 2001). 
These findings suggest that exercise is a viable alternative intervention. Yoga has also shown in 
previous research to be effective for treating depression. A study that looked at 5 randomized 
controlled trials found that certain poses have significant effects on reducing depressive 
symptoms (Pilkington, Kirkwood, Rampes, & Richardson, 2005). For example, individuals who 
practiced Shavasana had a significantly higher reduction in depressive symptoms compared to 
the individuals who did not receive an intervention. Yoga as an intervention for depression is still 
being researched, but has so far been seen as beneficial for treating depression. Meditation as 
another form of alternative intervention uses mindfulness-based stress reduction. The 
effectiveness of mindfulness-based stressed reduction on mental health has shown to be 
significant with a Cohen’s d of 0.54 (Grossman, Niemann, Schmidt, & Walach, 2004). Overall 
alternative interventions have demonstrated just as high potentials for efficiently reducing 
depressive symptoms as CBT and antidepressant medication.          
To examine how CBT, antidepressant medication, and alternative interventions compare 
to one another for treating depressive symptoms, Khan and colleagues (2012) conducted a study 
that compared the efficacy of each treatment to the other. In a previous study, the effectiveness 
of CBT was compared to the effectiveness of antidepressant medication for treating depressive 
symptoms. Khan and colleagues (2012) compiled a meta-analysis that involved data from 
multiple trial studies conducted by the FDA on antidepressant medication and patients diagnosed 
with depression. The researchers reviewed previous studies that evaluated the efficacy of 
TREATMENT PREFERENCE   6 
psychotherapy and alternative types of therapy on patients diagnosed with depression. The 
results of the study indicated that antidepressants had a significantly higher impact on the 
reduction of depressive symptoms than the placebo (Khan et al., 2012). Interestingly, the 
treatment type was a significant predictor of symptom reduction for both un-blinded and blinded 
trials. However, the magnitude of significance differed in the blinded trials. The percent of 
reduction in symptoms for the blinded trials for combination therapy was 53%, whereas the 
percent of reduction in symptoms for the un-blinded trials was 66% (Khan et al., 2012). The un-
blinded and blinded trials resulted in similar symptom reduction for the treatments of 
antidepressants, psychotherapy, and intervention control; therefore there is no significant 
difference in symptom reduction for type of treatment. Khan and colleagues (2012) did find, 
however, that antidepressants and psychotherapy were superior to all other control treatments, 
including the placebo control. These findings suggest that even though there may be a placebo 
effect associated with treating depression, medication and psychotherapy both have higher 
efficacies when reducing depressive symptoms. 
 Antidepressant medication and CBT were the dominant forms of treatment for major 
depression disorder. However, research suggests that several non-clinical interventions are also 
effective in reducing symptoms of depression (Babyak et al., 2000). For example, numerous 
studies suggest that regular engagement in physical exercise can lead to significant reductions in 
depressive symptomology. Babyak and colleagues (2000) designed a study that examined the 
effectiveness of aerobic exercise across a 4-month period for adults with major depressive 
disorder. After the 4-month period was over, participants returned for a 6 month follow-up. Of 
the participants in the exercise group, 60.4% no longer met the DSM-IV criteria for major 
depression (Babyak et al., 2000). At the 10 month follow-up session, only 30% of the 
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participants in the exercise group exhibited major depressive symptoms (Babyak et al., 2000). In 
a similar study, the HRSD scores that were compared before and after administering exercise 
showed an improvement in depressive symptoms (Singh, Clements, & Fiatarone, 1997). When 
compared to the control group, depressive symptoms improved 2 to 3 times greater for 
participants in the exercise group. When looking at response rates for exercise and the control 
group, 59% of the participants in the exercise group responded to treatment while only 26% 
responded in the control (Singh, Clements, & Fiatarone, 1997). The control group involved 
participants attending lectures on health education. These results demonstrate that exercise is an 
effective form of treatment that has significant results when compared to control conditions.     
To support the evidence of exercise as an effective form of treatment, Mead and 
colleagues (2009) carried out a systematic review that looked at the effectiveness of exercise in 
treating depression. The studies that they included were randomized controlled trials, and the 
type of participants were men and women aged 18 and older (Mead et al., 2009). There were two 
different types of interventions that the researchers looked at within the studies. The 
interventions included studies comparing exercise with no other intervention and studies 
comparing exercise to another intervention. The results of the systematic review indicated that 
exercise has a large effect (-0.82) on depressive symptoms compared with no treatment (Mead et 
al., 2009). Therefore, exercise has the potential effectiveness to be considered as an alternative 
for treating depression. 
 In a recent meta-analysis, Khan and colleagues (2012) compared the efficacy of various 
treatments for depression, including psychotherapy, medication, and alternative therapies, such 
as exercise. Exercise appears to be equally effective as psychotherapy and antidepressant 
medications in treating depression (Khan et al., 2012). All three of the forms of treatment 
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resulted in the reduction of depressive symptoms. These findings suggest that exercise can be 
equally as effective for treating depression as psychotherapy and antidepressant medications.  
 In order to provide the optimal amount of care when treating a patient, research suggests 
that clinicians should incorporate evidence based practice (Peterson, Becker, Treasure, Shafran, 
& Bryant-Waugh, 2016). Evidence-based practice is often thought of as a three legged stool that 
attempts to integrate the best available research evidence, clinical expertise, and patient values, 
preferences, and characteristics into clinical decision-making. The research evidence aspect of 
the stool refers to the most current empirical evidence of efficacy and effectiveness for treatment 
(Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). This empirical evidence is based on 
different research designs such as meta-analysis, randomized controlled studies, and systematic 
reviews. The importance of empirical evidence when used with clinical expertise and patient 
values and preferences is that treatments that may not be acceptable to the patients are able to be 
identified. The three legged stool also allows for dissemination and implantation of evidence 
based treatments which are significant for selecting patient interventions (Sackett, Rosenberg, 
Gray, Haynes, & Richardson, 1996). This allows for the most advanced interventions to be used 
when personalizing treatments for each patient. This is all determined by how efficiently the 
clinician is trained to provide treatments that are selected and preferred by patients, thus 
highlighting how important it is for clinicians and physicians to know what patients want in an 
intervention (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). The last component of 
empirical evidence is significant in situations where all treatments are equally effective.  
The last leg of the stool is patient preference, values, and characteristics (Sackett, 
Rosenberg, Gray, Haynes, & Richardson, 1996). When the interventions for treating depression 
are equally effective, the type of treatment preferred by the patient is important. With regards to 
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mental health, Peterson and colleagues (2016) stated that researchers study patient perspective 
and values under the categories of patient preference and expectations. Patient expatiations are 
where the patient foresees the outcomes of the treatment and the probability of improvement 
(Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). The expectations underlie the placebo 
effect to ensure the effectiveness of the actual treatment. Where having the option to choose a 
preference may not affect the outcome, there may be evidence that suggests patients with 
motivation to do well will benefit more from the treatment than the patients who have low 
expectations (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). Overall, the need for 
treatment preference is transparent where patients may benefit more if given control over their 
treatment with adequate amount of information in relation to the treatment.  
To understand the treatment preference among individuals with depression, a study was 
conducted to identify the preference of pharmacological or psychological treatment for 
depression (Dwight-Johnson, Sherbourne, Liao, & Wells, 2000). Of the 321 participants, 27% 
preferred antidepressant medication, 29% preferred individual counselling, and 26% preferred 
group counselling for treating depression (Dwight-Johnson, Sherbourne, Liao, & Wells, 2000). 
Participants who had previously received treatment and had symptoms only were more likely to 
want treatment. Of the patients who preferred medications over counseling, the factors that were 
associated with this were female gender, African American ethnicity, greater knowledge about 
counseling, and no recent antidepressant treatment (Dwight-Johnson, Sherbourne, Liao, & Wells, 
2000). The study overall found that participants prefer counseling over medication.  
With regards to patient preference for treatment, researchers have conducted a meta-
analysis that examines patient’s preference for psychological or pharmacological treatment for 
psychiatric disorders (McHugh, Whitton, Peckham, Weldge, & Otto, 2013). Overall the meta-
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analysis included 34 studies where there were a total of 90,483 participants. The most commonly 
examined disorder in the studies was depression (65% of studies). Of the total population of 
participants, the mean proportion of people who preferred psychological treatment was 0.75 
(McHugh, Whitton, Peckham, Weldge, & Otto, 2013). The authors observed that this was 
significantly higher than the proportion of the participants that chose both psychological and 
pharmacological treatment as their preference which had a mean proportion of (0.50). Across all 
subgroups, participants indicated that they preferred psychological treatment over 
pharmacological treatment (McHugh, Whitton, Peckham, Weldge, & Otto, 2013). Depression 
was included as one of the subgroups. The treatment seeking sample, when compared to the non-
treatment seeking sample, had a higher preference for psychotherapy than pharmacotherapy. In 
the study, the use of an alternative treatment option did not influence the preference for 
psychotherapy. Interestingly, McHugh and colleagues (2013) found that age was significantly 
associated with preference for psychological treatment. Younger participants were more likely to 
choose psychotherapy than older participants. Another significant finding was that gender was 
associated with preference for psychological treatment (McHugh, Whitton, Peckham, Weldge, & 
Otto, 2013). Women preferred psychological treatment at higher rates than men. Therefore, when 
patients are given the choice as to what type of treatment they prefer for psychiatric disorders, 
the majority of the time they prefer psychological treatment over pharmacological treatment.  
Prior to the McHugh et al. (2013) meta-analysis, Churchill and colleagues (2000) 
published a study that examined the factors that affected depressed patients’ treatment 
preference. Some of the factors that the researchers studied were sex, age, and previous 
experience of treated depression. The study in this article involved a self-completion 
questionnaire survey, where the participant sample included adult patients attending 20 general 
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practices in the Trent Region (Churchill et al. 2000). There were 895 participants who completed 
the questionnaire. Of the participants 32% were male and 68% were female. The researchers 
found that 29.1% of the respondents reported having personal experience of being treated for 
depression, and of these respondents 75.8% reported they had been previously treated with 
medications, 28.5% had seen a counsellor or psychologists, and 8% were referred to a 
psychiatrist (Churchill et al. 2000). Interestingly, men reported that they believed antidepressants 
were addictive at a higher rate than women. For treatment preference, 50.8% of the respondents 
favored counselling over drug treatment (15.3%) (Churchill et al. 2000). The association for 
female sex, previous experience with counselling, and the view that antidepressant are addictive 
was positive. Interestingly, age was not significantly associated with preference for counseling 
(p= 0.673) while female sex was (p= 0.005). Having prior experience with medications was not 
significantly associated with preferring counselling (p= 0.490), but having prior experiences with 
a counselor was (p= 0.016) (Churchill et al. 2000). The researchers concluded that overall 
counselling is preferred over antidepressants for the treatment of depression.  
To look at if patient preference for treatment for depression affected the outcome of 
treatment, Kwan, Dimidjian, & Rizvi (2010) conducted a study that compared the outcomes for 
patients’ preferences of pharmacotherapy and psychotherapy for depression. There were 106 
participants, and of those participants 68 were female and 38 were male (Kwan, Dimidjian, & 
Rizvi, 2010). Before participants were randomly assigned to conditions, they filled out a 
questionnaire that asked them about their treatment preference for depression. Participants were 
then randomly assigned to either the conditions of psychotherapy, antidepressant medication, or 
placebo pill by a computer generator (Kwan, Dimidjian, & Rizvi, 2010). The Beck Depression 
Inventory-II and the 17- item Hamilton Rating Scale for Depression were used to assess 
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depressive severity in the participants. Treatment preference of the participants was assessed by 
using the Expectations of Treatment Inventory. This allowed for participants to indicate whether 
or not they would prefer pharmacotherapy, psychotherapy, or neither for treating depression. The 
participants were also able to report if they expected psychotherapy or pharmacotherapy to yield 
effective results when treating depression, or if they thought one treatment would benefit more 
so than the other. The findings of Kwan, Dimidjian, & Rizvi (2010) study, prior to participants 
being assigned to separate conditions, were that 51 participants (48.1%) preferred psychotherapy, 
19 (17.9%) preferred antidepressant medication, and 36 (34.0%) expressed no interest for 
treatment of depression. There was an association between participants being assigned to the 
condition of their preference and when they were not. When participants were not matched to 
their treatment preference, they were more likely to drop-out of the study (Kwan, Dimidjian, & 
Rizvi, 2010). Participants who were matched with their treatment preference were less likely to 
drop-out of the study; therefore they had a significant outcome with decreasing depression 
severity. These results suggest that when patients are able to choose their preferred treatment, 
they are more likely to continue treatment, thus there is a higher chance that their depressive 
symptoms will decrease (Kwan, Dimidjian, & Rizvi, 2010).  
There is limited evidence and data with regards to the preference for exercise in treating 
depression. However, Busch and colleagues (2016) analyzed the types of exercise programs and 
content of the programs participants would want if they were interested in exercise for treatment. 
The researchers asked the preferences for location, social environment, coaching status, coaching 
format, frequency, duration, intensity, and the type of exercise. The results indicated that there 
were significant differences in the preferences of men and women for exercise content and type 
of exercise program (Busch et al. 2016). The most common preferred exercise among both men 
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and women was walking. Even though the study only looked at preference for characteristics 
involving exercise, participants still indicated that they were willing to consider exercise as a 
treatment even if they were currently in treatment for depression (Busch et al. 2016).  
When looking at the preference for exercise relative to psychotherapy and medications, 
Raue and colleagues (2011) examined depression treatment preference for elderly home care 
patients. The patients were asked in a survey if they preferred active treatment (antidepressant 
medication, psychotherapy, or combination) or complementary treatment (spiritual activities or 
exercise). The findings in the study were 47% of the patients’ preferred active treatment, and 
53% of the patients’ preferred complementary treatment (Raue et al. 2011). When looking at the 
preferences for patients who were currently using antidepressants, 77% indicated a preference 
for active treatment while only 57% of the patients who used antidepressants in the past 
indicated a preference for active treatment (Raue et al. 2011). Overall, there was relativity an 
equivalent number of patients who chose psychotherapy and antidepressant medication, and 
exercise was one of the most preferred forms of complementary treatment. There is still a limited 
amount of research on the preference for exercise when compared to psychotherapy and 
antidepressant medication among people who are not elderly home care patients.    
The current study addresses the gap in research on the preference of exercise for treating 
depression when patients are given the option of CBT, medication, and exercise. Previous 
research has only analyzed the preference amongst CBT and medication for treatment of 
depression. However, there has been some research on whether or not patients would consider 
exercise for treating depression, but no study has looked at exercise as a preference in relation to 
CBT and medications. In this study, I hypothesized that when individuals are given the option of 
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exercise with CBT and medication for treatment of depression, individuals will prefer exercise 
over medications for treatment. 
Methods 
Participants. Participants consisted of 389 (237 females and 152 males) individuals 
recruited through Amazon’s Mechanical Turk (MTurk). Participant’s ranged in age from 19 to 
76 (M = 37.50, SD = 13.54). The racial breakdown of participants included: White/Caucasian – 
Non Hispanic (75.6%), African American or Black (6.9%), Hispanic or Latino (6.4%), Asian 
(6.9%), American Indian or Alaska Native (0.8%), more than one race (3.1%), and other race not 
listed (0.3%). Participants that completed the survey were compensated with 40 cents.  
Procedure. Participants were recruited through MTurk with a link that provided them the 
opportunity to complete a survey about their “treatment preferences” in exchange for 40 cents of 
compensation. Participants who clicked on the link were directed to a Qualtrics survey 
containing an informed consent page. Those who agreed to the terms of the consent form were 
presented with the following scenario:  
“Imagine that you are 25 years old and have been experiencing intense sadness for the 
past month. During that time, you have not been interested in activities that you typically 
enjoy, and you feel hopeless about things improving in the future. You have low energy, 
and just getting out of bed seems to be an exhausting task. You have been eating and 
sleeping more than usual, but you are still tired all the time. You feel worthless and have 
even begun to think that your family might be better off if you were dead. Due to your 
difficulties, you have stopped interacting with friends and family, and you have missed 
several days of work. Your friends and family are becoming increasingly frustrated with 
your lack of contact, and your boss told you that if you miss any more time at work, you 
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will be fired. You recently decided that you do not want to live this way anymore, and 
you made an appointment to seek help. At your appointment, your concerns are reviewed, 
and you are informed that you meet criteria for Major Depressive Disorder. You are 
presented with the following treatment options.” 
Participants were then presented with three treatment options in randomized order: cognitive 
behavioral therapy, Sertraline, and physical exercise. Participants were asked to rate the 
likelihood that they would select each treatment option on a three-point scale (would not select, 
would possibly select, would definitely select) and to identify the treatment they would select if 
they could choose one of the listed treatment options. Upon completing the survey, participants 
were provided with a survey completion code, which they were required to enter into the MTurk 
site to receive their compensation.  
Results 
A series of paired-samples t-tests were conducted to compare the likelihood participants 
would select each of the three treatment options (exercise, cognitive behavioral therapy, or 
sertraline) for major depressive disorder. In this analysis, participants’ selections were not 
mutually exclusive as they were permitted to select as many of the treatment options as they 
preferred. As seen in Figure 1, results indicated that participants were significantly more likely to 
select cognitive behavioral therapy (M = 2.41, SD = 0.71) than exercise (M = 2.29, SD = 0.62; 
t(372) = -2.76, p = 0.006) and sertraline (M = 1.88, SD = 0.70; t(372) = 10.99, p < 0.001) for the 
treatment of major depressive disorder. In addition, participants were significantly more likely to 
select exercise than sertraline, t(372) = 7.57, p < 0.001. As seen in Figure 2, when asked to select 
their preferred treatment method of only able to choose one, participants most frequently selected 
cognitive behavior therapy (44%), followed by exercise (32%) and Sertraline (24%). 
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Discussion 
 The present study examined the treatment preferences for cognitive behavioral therapy, 
exercise, and sertraline for major depressive disorder. Previous research has suggested that 
individuals generally report preferring cognitive behavioral therapy to psychiatric medications at 
a rate of approximately three to one. Results of the present study indicated that, when physical 
exercise is presented as a treatment option in addition to cognitive-behavioral therapy and 
psychiatric medication, cognitive behavioral therapy continues to be preferred at a significantly 
higher rate than medication, with medication continuing to be preferred by only approximately 
25 percent of the sample. Notably, physical exercise was also perceived as significantly more 
preferable than pharmacological intervention, though exercise was less preferable than cognitive 
behavioral therapy.  
The results of the present study are consistent with recent research indicating that when 
participants or patients are given the option of choosing cognitive behavioral therapy or 
medication, they are significantly more likely to choose cognitive behavioral therapy than 
medication at a rate of approximately three to one (Deacon & Abramowitz, 2005). Interestingly, 
when exercise was added to the mixture of choices, approximately 24 percent of participants 
selected medication, which is highly consistent with the rates observed in previous research. 
However, the rate of those who preferred cognitive behavioral therapy was only 44 percent, with 
an additional 32 percent selecting exercise. Thus, when compared to previous research, it appears 
that adding the option of exercise as an intervention for depression leads approximately 42 
percent of those who would otherwise have selected cognitive behavior therapy to select exercise 
as an intervention instead. These results may indicate that individuals are seeking treatment that 
is convenient and cost effective, while both cognitive behavioral therapy and medications have a 
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high cost investment. Also, individuals who have previously preferred cognitive behavioral 
therapy may not have known exercise was another treatment option, and they would rather prefer 
a treatment that is more convenient for their time schedule. 
Across literature, cognitive behavioral therapy has been preferred over antidepressant 
medication for treating major depression (McHugh, Whitton, Peckham, Weldge, & Otto, 2013). 
The preference for cognitive behavioral therapy emphasizes the need for physicians to improve 
their patients’ access to evidence-based treatments. When individuals are given the option of 
having a choice in the treatment they prefer, the majority are leaning more towards psychological 
treatments, which is notable in that it suggests that evidence-based treatment is crucial in the 
primary-care setting. Masic, Miokovic, & Muhamedagic (2008) suggest that there may be a gap 
between research and practice where doctors are not staying on top of new research for 
treatments. This may account for physicians providing patients with the lack of treatment 
options, where the physicians may be deciding the best treatment option for the patient. Thus, the 
patient may be prescribed antidepressant medication. Evidence-based practice would allow the 
individual to weigh out their options based on previous research and decide for themselves what 
they think would be the most effective treatment.  
The option for patients to choose the treatment they prefer may also elicit more effective 
outcomes (Swift & Callahan, 2009). A systematic review of the literature provided evidence that 
when patients are given the option of choosing the treatment they prefer, the patients were less 
likely to drop-out of the trial, and they were more likely to see positive results. However, even 
though patient preference allows for positive outcomes, the patient may not know the 
effectiveness of the treatment without consulting with their physician (Swift & Callahan, 2009). 
This may indicate that patient preference alone is not helpful, but if physicians would provide 
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their patients with evidence-based treatment options, then the patient may be able to choose the 
treatment option best suited for them. 
 Previous research has only investigated whether or not people would be willing to try 
exercise for a treatment of major depression disorder. For instance, Busch and colleagues (2016) 
examined the preference of exercise on an online survey. The researchers found that 61.8% of 
the participants said they were willing to try exercise as a treatment. However, the researchers 
did not compare exercise with other treatment options such as cognitive behavioral therapy and 
medication. The current study looked at the comparison between the three types of treatments 
and found exercise to be preferred over medication.   
 There are several limitations of the present study that should be noted. First, the current 
study may not generalize to an actual primary care setting. The participants in this study were not 
seeking help while patients in a primary care setting would be. Patients who are seeking help 
may perceive the treatment options differently, or they may not be given treatment options by 
their primary care physician. Therefore, even though the participants are claiming they would 
prefer cognitive behavioral therapy over medication, patients may not know they have options. 
This may be occurring because primary-care physicians are prescribing antidepressant 
medication to patients who are not aware of evidence-based treatments that may work better 
which includes cognitive-behavioral therapy (Smith, 2012). Second, while participants were 
given the option of whether or not they would choose a specific treatment, they were not given 
the option of choosing a combination of two treatments in the same time period. Findings may 
have differed if participants were specifically asked to choose a combination of each treatment. 
Third, there could have been treatment biases for participants who were currently or previously 
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treated for major depressive disorder. Being treated for major depression could have influenced 
the treatment preferred by participants, on the basis of which treatment they used.  
   
 
 
     
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TREATMENT PREFERENCE   20 
References 
Babyak, M., Blumenthal, J., Herman, S., Khatri, P., Doraiswamy, M., Moore, K., Craighead, E., 
Baldewicz, T., & Krishnan, K., (2000). Exercise treatment for major depression: 
Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine, 62, 633-638. 
doi: 10.1097/00006842-200009000-00006  
Breslau, J., Miller, E., Jin, R., Sampson, N., Alonso, J., Andrade, L., Bromet, E., de Girolamo, 
G., Demyttenaere, K., Fayyad, J., Fukao, A., Galaon, M., Gureje, O., Hinkov, H., Hu, C., 
Kovess-Masfety, V., Matschinger, H., Medina-Mora, M., Ormel, J., Posada-Villa, J., 
Sagar, R., Scott, K., & Kessler, R., (2011). A multinational study of mental disorders, 
marriage, and divorce. Acta Psychiatrica Scandinavica, 124, 474-486. doi: 
10.1111/j.1600-0447.2011.01712.x 
Busch, A., Ciccolo, J., Puspitasari, A., Nosrat, S., Whitworth, J., & Stults-Kolehmainen, M., 
(2016). Preferences for exercise as a treatment for depression. Mental Health Phys Act, 
10, 68-72. doi:10.1016/j.mhpa.2015.12.004. 
Churchill, R., Khaira, M., Gretton, V., Chilvers, C., Dewey, M., Duggan, C., & Lee, A., (2000). 
Treating depression in general practice: factors affecting patients’ treatment preferences. 
British Journal of General Practice, 50, 905-906. PMCID: PMC1313855 
 Dwight-Johnson, M., Sherbourne, C., Liao, D., & Wells, K., (2000). Treatment preferences 
among depressed primary care patients. Journal of General Internal Medicine, 15, 527-
534. doi:10.1046/j.1525-1497.2000.08035.x 
Deacon, B., & Abramowitz, J., (2005). Patients’ perceptions for pharmacological and cognitive- 
behavioral treatments for anxiety disorders. Behavior Therapy, 36, 139-145. 
doi: 10.1016/S0005-7894(05)80062-0 
TREATMENT PREFERENCE   21 
Facts & statistics. (2016, August). Anxiety and Depression Association of America. Retrieved 
from www.adaa.org. 
Fournier, J., DeRubeis, R., Hollon, S., Dimidjian, S., Amsterdam, J., Shelton, R., & Fawcett, J., 
(2010). Antidepressant drug effects and depression severity: A patient-level meta-
analysis. JAMA, 303, 47-53. doi:10.1001/jama.2009.1943 
Gaffan, E., Tsaousis, L., & Kemp-Wheeler, S., (1996). Researcher allegiance and meta-analysis: 
The case of cognitive behavior therapy for depression. Journal of Consulting and 
Clinical Psychology, 63, 966-980. doi:10.1037//0022-006X.63.6.966 
Gonda, X., Pompili, M., Serafini, G., Carvalho, A., Rihmer, Z., & Dome, P., (2015). The role of 
cognitive dysfunction in the symptoms and remission from depression. Annals of General 
Psychiatry, 14, 27, doi:10.1186/s12991-015-0068-9.  
Grossman, P., Niemann, L., Schmidt, S., & Walach, H., (2004). Mindfulness-based stress 
reduction and health benefits: A meta-analysis. Journal of Psychosomatic Research, 57, 
35-43. doi: 10.1111/j.2042-7166.2003.tb04008.x 
Holtzheimer, P., & Mayberg, H., (2011). Stuck in a rut: Rethinking depression and its treatment. 
Trends in Neuroscience, 34, 1-9. doi: 10.1016/j.tins.2010.10.004 
Keller, M.B., (1994). Depression: a long-term illness. The British Journal of Psychiatry, 29, 9-
15.  
Kessler, R., (2012). The costs of depression. Psychiatric Clinics of North America, 35, 1-14. doi: 
10.1016/j.psc.2011.11.005 
Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., & Brown, W., (2012). A systematic review of 
comparative efficacy of treatments and controls for depression. Public Library of Science 
7, e41778. doi: 10.1371/journal.pone.0041778 
TREATMENT PREFERENCE   22 
Kwan, B., Dimidjian, S., & Rizvi, S., (2010). Treatment preference, engagement, and clinical 
improvement in pharmacotherapy versus psychotherapy for depression. Behavior 
Research and Therapy, 48, 799-804. doi: 10.1016/j.brat.2010.04.003 
Lawlor, D., (2001). The effectiveness of exercise as an intervention in the management of 
depression: systematic review and meta-regression analysis of randomized controlled 
trials. BJM, 322, 736. doi: https://doi.org/10.1136/bmj.322.7289.763. 
Masic, I., Miokovic, M., & Muhamedagic, B., (2008). Evidence based medicine – new 
approaches and challenges. Journal of Academy of Medical Sciences of Bosnia and 
Herzegovina, 16, 219-225. doi: 10.5455/aim.2008.16.219-225 
McHugh, K., Whitton, S., Peckham, A., Weldge, J., & Otto, M., (2013). Patient preference for 
psychological vs. pharmacological treatment of psychiatric disorders: A meta-analysis 
review. The Journal of Clinical Psychiatry, 74, 595-602. doi: 10.4088/JCP.12r07757 
Mead, G., Morley, W., Campbell, P., Greig, C., McMurdo, M., & Lawlor, D., (2009). Exercise 
for depression. Cochrane Database of Systematic Reviews, 3, 
doi:10.1002/14651858.CD004366.pub4 
Nahas, R., & Sheikh, O., (2011). Complementary and alternative medicine for the treatment of 
major depressive disorder. Canadian Family Physician, 13, 659-663. PMCID: PMC3114664 
Peterson, C., Becker, C., Treasure, J., Shafran, R., & Bryant-Waugh, R., (2016). The three-
legged stool of evidence-based practice in eating disorder treatment: research, clinical, 
and patient perspective. BMC Medicine, 14, 69, doi: 10.1186/s12916-016-0615-5. 
Pilkington, K., Kirkwood, G., Rampes, H., & Richardson, J., (2005). Yoga for depression: the 
research evidence. Journal of Affective Disorders, 89, 13-24. doi: 
10.1016/j.jad.2005.08.013 
TREATMENT PREFERENCE   23 
PubMed Health, (2017). Depression: How effective are antidepressants? U.S. National Library 
of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0087089/. 
Raue, P., Weinberger, M., Sirey, J., Meyers, B., & Bruce, M., (2011). Depression treatment 
preferences in home healthcare. Psychiatric Service, 62, 532-537. 
doi:10.1176/appi.ps.62.5.532 
Sackett, D., Rosenberg, W., Gray, J., Haynes, R., & Richardson, W., (1996). Evidence based 
medicine: what is it and what it isn’t. BMJ, 312, 71-72. doi: 
https://doi.org/10.1136/bmj.312.7023.71 
Saeed, S., Antonacci, D., & Bloch, R., (2010). Exercise, yoga, and meditation for depressive and 
anxiety disorders. American Family Physician, 81, 981-986.  
Simon, G., VonKorff, M., & Barlow, W., (1995). Health care costs of primary care patients with 
recognized depression. Archives of General Psychology, 52, 850-856. 
doi:10.1001/archpsyc.1995.03950220060012 
Singh, N., Clements, K., & Fiatarone, M., (1997). A randomized controlled trial of progressive 
resistance training in depressed elders. Journal of Gerontology: Medical Sciences, 52, 27-
35. doi: 10.1093/gerona/52A.1.M27 
Smith, B., (2012). Inappropriate prescribing. Monitor, 43, 36.  
Swift, J., & Callahan, J., (2009). The impact of client treatment preference on outcome: A meta-
analysis. Journal of Clinical Psychology, 65, 368-381. doi: 10.1002/jclp.20553 
 
TREATMENT PREFERENCE   24 
 
 
Figure 1. Treatment preference for CBT, exercise, and Sertraline for major depressive disorder.  
 
 
 
 
Figure 2. Likelihood of selecting CBT, exercise or Sertraline for major depressive disorder. 
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